Upstream Bio (UPB) FCF Margin (2023 - 2026)

Upstream Bio's FCF Margin history runs 4 years deep, the most recent figure standing at 4627.85% for Q1 2026.

• In Q1 2026, FCF Margin rose 264512.0% year-over-year to 4627.85%; the TTM figure through Mar 2026 stood at 4216.74% (down 59509.0% YoY), while the FY2025 annual figure was 4675.54%, down 215727.0% from the prior year.
• FCF Margin for Q1 2026 stood at 4627.85%, down from 4601.95% in the prior quarter.
• The five-year high for FCF Margin was 1575.69% in Q2 2024, with the low at 7272.97% in Q1 2025.
• The 4-year median for FCF Margin is 3420.51% (2023), against an average of 3740.88%.
• The sharpest annual moves came in 2025 and 2026: FCF Margin sank 452891 bps in 2025, then soared 264512 bps in 2026.
• Upstream Bio's FCF Margin stood at 3580.0% in 2023, then increased by 9 bps to 3261.01% in 2024, then slumped by 41 bps to 4601.95% in 2025, then dropped by 1 bps to 4627.85% in 2026.
• Business Quant data shows UPB's FCF Margin at 4627.85% in Q1 2026, 4601.95% in Q4 2025, and 3257.39% in Q3 2025.